Thousands tracked to see if synthetic artery grafts hold up over time
NCT ID NCT07161583
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This registry follows 1000 people who received Advanta VXT or Flixene grafts to repair peripheral arteries. Researchers will check how well the grafts stay open and how often serious problems like amputation or repeat surgery occur. The goal is to confirm these devices are safe and work well over the long term.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Advanta VXT and Flixene vascular grafts (synthetic tubes used to replace or repair damaged arteries)
- What this could lead to
- If successful, this registry could confirm that these grafts are safe and effective for long-term use, helping doctors choose better options for peripheral artery disease.
- What could go wrong
- This is an observational registry, not a controlled trial, so results may not prove cause and effect. Grafts can still fail or cause complications like infection or blockage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Brest
RECRUITINGBrest, Brittany Region, France
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a phone app replace cardiac rehab? a new trial puts digital heart care to the test
- Ozone therapy put to the test: could it harm your eyes?
- Biodegradable artery graft could revolutionize leg bypass surgery
- Could an arthritis drug shield heart and kidneys in metabolic syndrome?
- Sound waves could blast away artery blockages without surgery
- New stent graft aims to restore blood flow in legs without major surgery